Women who use the antidepressant drug Celexa during pregnancy are more likely to give birth to children with serious and potentially fatal birth defects including persistent pulmonary hypertension of the newborn (PPHN), craniosynostosis and congenital heart defects.
Celexa is an antidepressant in the group of drugs known as selective serotonin reuptake inhibitors (SSRIs). Celexa can also prescribed for attention deficit hyperactivity disorder (ADHD), obsessive compulsive disorder (OCD) and premenstrual dysphoric disorder (PMDD).
Studies show that use of Celexa during the first trimester of pregnancy increases the likelihood of the infant having craniosynostosis, which can result in impaired vision and impaired mental development.
The New England Journal of Medicine reported that babies exposed to antidepressants such as Celexa in the last trimester of pregnancy were six times more likely to be born with persistent pulmonary hypertension (PPHN) of the newborn than babies who were not exposed. PPHN is a serious and potentially fatal circulatory condition. Other possible birth defects resulting from the use of Celexa during pregnancy include Autism Spectrum Disorder, clubfoot, cleft lip or cleft palate, and anal atresia.
If you or a loved one used Celexa or other antidepressants during pregnancy and gave birth to a child with PPHN or other birth defects, contact the lawyers at Hissey Kientz, LLP to learn more about your legal rights. You can reach us by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form to the right of this page.